Revive Therapeutics Webcast – February 10, 2022



Michael Frank, Chairman & CEO and Derrick Welsh, COO give investors an update on the current phase III bucillamine trial for …

source

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *